Expression profiling of breast cancer, influence of tumor genotype and patient genotype

Por Borresen-Dale, A-L
Publicado em 2003

Expression profiling of peripheral blood cells for early detection

Por Børresen-Dale, A-L, Sharma, P
Publicado no Breast Cancer Res (2005)

Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite repeat

Por Nedelcheva Kristensen, V, Kristensen, T, Børresen-Dale, A-L
Publicado em 2000

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

Por Langerød, A, Andersen, TI, Bukholm, I, Børresen Dale, A-L
Publicado em 2000

Promising method for DNA extraction from paraffin embedded archive material

Por Bregård, A, Vu, P, Geitvik, G, Børresen-Dale, A-L
Publicado em 2000

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway

Por Joshi, H, Bhanot, G, Børresen-Dale, A-L, Kristensen, V
Publicado em 2012

Gene expression studies in radiation-sensitive cell lines

Por Aarøe, J, Gatti, R, Børresen-Dale, A-L, Rødningen, O
Publicado no Breast Cancer Res (2005)

Application of microarray analyses to identify genes involved in radiation-induced fibrosis

Por Rødningen, OK, Alsner, J, Hastie, T, Overgaard, J, Børresen-Dale, A-L
Publicado no Breast Cancer Res (2005)

Relation of gene expression-based tumor subclasses to clinical phenotypes

Por Sørlie, T, Perou, CM, Lønning, PE, Brown, PO, Botstein, D, Børresen-Dale, A-L
Publicado em 2000

Promoter composition predicts gene classes in microarray expression analyses of breast cancer

Por Nordgard, SH, Sørlie, T, Chanock, SJ, Børresen-Dale, A-L, Gardner, K, Kristensen, VN
Publicado no Breast Cancer Res (2005)

X chromosome inactivation pattern in female patients with breast cancer

Por Kristiansen, M, Langer, A, Knudsen, GP, Weber, BL, Børresen-Dale, A-L, Ørstavik, KH
Publicado em 2000

Characterization of extracellular matrix composition in breast carcinoma

Por Bergamaschi, A, Tagliabue, E, Sørlie, T, Nesland, J, Orlandi, R, Ménard, S, Børresen-Dale, A-L
Publicado no Breast Cancer Res (2005)

Functional characterization of genes involved in the development of breast cancer

Por Gjernes, E, Størvold, GL, Askautrud, H, Børresen-Dale, A-L, Perou, CM, Frengen, E
Publicado no Breast Cancer Res (2005)

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Por Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G., Børresen-Dale, A. l.
Publicado em 1998

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

Por Smith-Sørensen, B., Kaern, J., Holm, R., Dørum, A., Tropé, C., Børresen-Dale, A. L.
Publicado em 1998

Expression of wild-type and mutated TP53 in breast carcinomas

Por Baumbusch, LO, Myhre, S, Langerød, A, Bergamaschi, A, Johnsen, H, Geisler, S, Lønning, PE, Børresen-Dale, A-L
Publicado no Breast Cancer Res (2005)

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

Por Akslen, L A, Straume, O, Geisler, S, Sørlie, T, Chi, J-T, Aas, T, Børresen-Dale, A-L, Lønning, P E
Publicado em 2011

Genetic polymorphisms in the 5' flanking region of glutathione S-transferase P1 affect promoter methylation

Por Rønneberg, JA, Tost, J, Grenaker-Alnæs, GI, Sørlie, T, Kristensen, T, Gut, I, Børresen-Dale, A-L, Kristensen, VN
Publicado no Breast Cancer Res (2005)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

Por Andersen, TI, Skovlund, E, Bukholm, IK, Jacobsen, U, Kåresen, R, Erikstein, B, Nesland, J, Børresen-Dale, A-L
Publicado em 2000

Screening breast cancer patients for Norwegian ATM mutations

Por Laake, K, Vu, P, Andersen, TI, Erikstein, B, Kåresen, R, Lønning, PE, Skovlund, E, Børresen-Dale, A-L
Publicado em 2000